Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Gains from Sales and Divestitures (2017 - 2023)

Ani Pharmaceuticals' Gains from Sales and Divestitures history spans 7 years, with the latest figure at $235000.0 for Q1 2023.

  • On a quarterly basis, Gains from Sales and Divestitures rose 45.96% to $235000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $235000.0, a 45.96% increase, with the full-year FY2022 number at $245000.0, up 96.0% from a year prior.
  • Gains from Sales and Divestitures hit $235000.0 in Q1 2023 for Ani Pharmaceuticals, down from $245000.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for ANIP hit a ceiling of $245000.0 in Q4 2022 and a floor of $34000.0 in Q1 2021.
  • Historically, Gains from Sales and Divestitures has averaged $126937.5 across 5 years, with a median of $125500.0 in 2021.
  • Biggest five-year swings in Gains from Sales and Divestitures: plummeted 30.61% in 2021 and later surged 373.53% in 2022.
  • Tracing ANIP's Gains from Sales and Divestitures over 5 years: stood at $42000.0 in 2019, then skyrocketed by 202.38% to $127000.0 in 2020, then decreased by 1.57% to $125000.0 in 2021, then soared by 96.0% to $245000.0 in 2022, then dropped by 4.08% to $235000.0 in 2023.
  • Business Quant data shows Gains from Sales and Divestitures for ANIP at $235000.0 in Q1 2023, $245000.0 in Q4 2022, and $234000.0 in Q3 2022.